PCOS Has Been Renamed PMOS. Here's What That Actually Means.

If you've ever been told your PCOS "isn't that bad" because your ultrasound looked manageable - while dealing with insulin resistance, irregular cycles, fatigue, and skin that won't cooperate - this rename is for you.

After a 14-year global consultation and over 22,000 responses from patients and clinicians, The Lancet published a correction nearly 90 years overdue.

PCOS is now PMOS: Polyendocrine Metabolic Ovarian Syndrome.

Why the old name was always incomplete.

PCOS was named in 1935 based on what doctors could see - follicles on the ovaries. The problem is that many women diagnosed with PCOS don't have abnormal cysts at all. The cysts were never really the point.

What the condition actually involves: multiple hormonal systems, insulin resistance, chronic inflammation, mental health, skin, and reproductive function - simultaneously. Naming it after one observable ovarian feature meant everything else got missed or minimised.

Professor Helena Teede, who led the global initiative, said the old name directly contributed to delayed diagnosis and inadequate treatment. The name itself caused harm.

What PMOS gets right.

Poly Endocrine - multiple hormonal systems are involved, not just the ovaries.
Metabolic - insulin resistance is central, not a side note. Ovarian - yes, the ovaries are part of it. One part.

A name shapes what doctors look for, measure, and treat. PMOS should push diagnosis toward a full metabolic and hormonal workup - not just a single ultrasound.

1 in 8 women in India live with this condition. They deserved a more accurate name a long time ago.

AKYA makes science-backed supplements for women navigating hormonal and metabolic health - including our Inositol (clinical ratio 40:1), formulated for PCOS/PMOS management.